Ultravate X (Ranbaxy Laboratories Inc.)
Welcome to the PulseAid listing for the Ultravate X drug offered from Ranbaxy Laboratories Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Ranbaxy Laboratories Inc. |
NON-PROPRIETARY NAME: | Halobetasol Propionate |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-07-01 |
END MARKETING DATE: | 0000-00-00 |
Ultravate X HUMAN PRESCRIPTION DRUG Details:
Item Description | Ultravate X from Ranbaxy Laboratories Inc. |
LABELER NAME: | Ranbaxy Laboratories Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2012-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 10631-119_94656dc4-95ad-4d89-9acd-f7a15854127e |
PRODUCT NDC: | 10631-119 |
APPLICATION NUMBER: | NDA019968 |